Northwestern Mutual Wealth Management Co. Purchases 649,058 Shares of HCA Healthcare, Inc. $HCA

Posted by Francis Steltz on May 16th, 2026

Northwestern Mutual Wealth Management Co. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 4,545.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 663,337 shares of the company’s stock after acquiring an additional 649,058 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in HCA Healthcare were worth $309,686,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of HCA. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $29,000. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $26,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at $31,000. Aventura Private Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at $34,000. Finally, Key Capital Management INC bought a new position in shares of HCA Healthcare in the fourth quarter valued at $35,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on HCA. Barclays reduced their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 price target on shares of HCA Healthcare in a research note on Friday, April 24th. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Truist Financial lowered their target price on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Finally, Wells Fargo & Company reduced their price target on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $517.82.

Check Out Our Latest Analysis on HCA

Insider Activity

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $422.68 on Friday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company has a fifty day moving average price of $478.74 and a 200-day moving average price of $485.84. The company has a market capitalization of $93.77 billion, a P/E ratio of 14.54, a PEG ratio of 1.37 and a beta of 1.18.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the previous year, the business posted $6.45 EPS. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.